In addition, it is also reported that CD36 is a shared downstream target of LXRα, PXR and PPARγ [74], and that LXRα-mediated CD36 induction is responsible for T0901317 treatment-mediated hepatic steatosis, which was abrogated in CD36 KO mice [74]. The gene discussed is NR1H3; the disease is fatty liver disease.